Literature DB >> 27178312

Protective effect of citicoline against aluminum-induced cognitive impairments in rats.

Ahmed O Abdel-Zaher1, Mostafa M Hamdy1, Mahran S Abdel-Rahman1, Doaa H Abd El-Hamid1.   

Abstract

The potential protective effect of citicoline on aluminum chloride-induced cognitive deficits was investigated in rats. In a Morris water maze, administration of aluminum chloride to rats for 90 days resulted in increased escape latency to reach the platform and decreased swimming speed in acquisition trials. Similarly, in probe trials, the time required to reach the hidden platform was increased and the time spent in the target quadrant was reduced. Also, administration of aluminum chloride to rats for 90 days increased the reference and working memory errors and time required to end the task in the radial arm maze. In addition, this treatment decreased the step-through latency in the passive avoidance test. Concurrently, treatment of rats with aluminum chloride for 90 days increased hippocampal glutamate, malondialdehyde, and nitrite levels and decreased intracellular reduced glutathione level. In the citicoline-treated group, aluminum chloride-induced learning and memory impairments as assessed by the Morris water maze, radial arm maze, and passive avoidance tests were inhibited. At the same time, treatment of rats with citicoline prevented the biochemical alterations induced by aluminum chloride in the hippocampus. It can be concluded that elevation of hippocampal glutamate level with consequent oxidative stress and nitric oxide (NO) overproduction may play an important role in aluminum-induced cognitive impairments. Also, our results suggest, for the first time, that citicoline can protect against the development of these cognitive deficits through inhibition of aluminum-induced elevation of glutamate level, oxidative stress, and NO overproduction in the hippocampus.

Entities:  

Keywords:  Aluminum chloride; citicoline; cognitive impairments; hippocampus

Mesh:

Substances:

Year:  2016        PMID: 27178312     DOI: 10.1177/0748233716641869

Source DB:  PubMed          Journal:  Toxicol Ind Health        ISSN: 0748-2337            Impact factor:   2.273


  7 in total

1.  Telmisartan Protects Against Aluminum-Induced Alzheimer-like Pathological Changes in Rats.

Authors:  Mona Khalifa; Marwa M Safar; Rania M Abdelsalam; Hala F Zaki
Journal:  Neurotox Res       Date:  2019-07-22       Impact factor: 3.911

2.  Phosphodiesterase (PDE) III inhibitor, Cilostazol, improved memory impairment in aluminum chloride-treated rats: modulation of cAMP/CREB pathway.

Authors:  Mona Khalifa; Rania M Abdelsalam; Marwa M Safar; Hala F Zaki
Journal:  Inflammopharmacology       Date:  2022-06-21       Impact factor: 5.093

3.  Expression of DnMTs and MBDs in AlCl3-Induced Neurotoxicity Mouse Model.

Authors:  Muhammad Faisal Ikram; Syeda Mehpara Farhat; Aamra Mahboob; Saeeda Baig; Ahmed Yaqinuddin; Touqeer Ahmed
Journal:  Biol Trace Elem Res       Date:  2020-11-11       Impact factor: 3.738

4.  Magnesium Increases the Protective Effect of Citicoline on Aluminum Chloride-induced Cognitive Impairment.

Authors:  Ali Hosseini-Sharifabad; Mohammad Rabbani; Yasaman Seyed-Yousefi; Maryam Safavi
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-05-31       Impact factor: 2.582

5.  Trichoderma reesei fungal degradation boosted the potentiality of date pit extract in fighting scopolamine-induced neurotoxicity in male rats.

Authors:  Samar R Saleh; Asmaa M Masry; Doaa A Ghareeb; Al-Sayeda A Newairy; Eman Sheta; Adham M Maher
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

6.  Posible involvement of nitric oxide in anticonvulsant effects of citicoline on pentylenetetrazole and electroshock induced seizures in mice.

Authors:  Rokhsana Rasooli; Fatema Pirsalami; Leila Moezi
Journal:  Heliyon       Date:  2020-05-19

7.  Protective Effects of Citicoline and Benfotiamine Each Alone and in Combination on Streptozotocin-induced Memory Impairment in Mice.

Authors:  Maryam Safavi; Ali Hosseini-Sharifabad; Yasaman Seyed-Yousefi; Mohammad Rabbani
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-02-29       Impact factor: 2.582

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.